BIOM-48. PTEN MUTATIONS PREDICT BENEFIT FROM TUMOR-TREATING FIELDS THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA

BACKGROUND: Glioblastoma IDH-wildtype (GBM-IDH-WT) recurs despite the standard of care which includes surgical resection and concurrent chemoradiotherapy. Optimal treatment for recurrent GBM-IDH-WT (rGBM) is not standardized and multiple therapeutic approaches are utilized. Clinical trials have show...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Dono, Antonio, Mitra, Sonali, Takayasu, Takeshi, Zhu, Jay-Jiguang, Tandon, Nitin, Esquenazi, Yoshua, Ballester, Leomar Y
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2020
Ämnen:
Biomarkers
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650355/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.045
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk